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in seven U.S. cities: Chicago, Detroit,
Houston, Los Angeles, Milwaukee, New
York, and Philadelphia. Looking at data
for 1986-1989, the researchers found that
3,250 (about 5.7%) of the cities' annual
congestive heart failure hospitalizations
correlatedwith an increase in air CO.
Thomas E. Dahms, a cardiovascular
physiologist at St. Louis University who
has studied CO, cautions that the study's
retrospective approach is limited. "For one
thing, congestive heart failure is a loosely
defined diagnosis," Dahms says. "To vali-
date its consistency between hospitals,
you'd have to do some spot checking of
patient records."
Dahms also worries whether air pollu-
tion readings accurately reflect an individ-
ual's exposure to CO. "There have been a
number ofstudies trying to relate personal
CO exposure levels to air readings picked
up at monitoring stations 50 to 100 feet
offthe ground," he says. "So far, there has
been littlevalidation in relating the two."
ButJoel Schwartz, an epidemiologist at
the Harvard School ofPublic Health who
wrote an editorial accompanying the study,
says the work is informative. "There is cer-
tainly a chance for misdiagnosis when
looking across cities," Schwartz says. "But
within any one city's analysis, it shouldn't
be a problem." Such misdiagnosis is
absorbed during statistical analysis, he says.
Schwartz adds that, despite inconsistencies,
there is a clear link between personal expo-
sure and air pollution readings: "The real
question is, IfI took everyone in this city,
averaged their personal exposure to CO
and correlated that, day to day, with the
average outdoor air pollution readings,
what would I find? Would the averages go
up and down together? We won't know
until we do more studies."
Morris agrees his findings are prelimi-
nary. "Clearly, this study raises as many
questions as it answers," he says. One
question involves the amount of CO that
exacerbates heart problems. The health
effects cited in this study occurred below
federally permissible CO levels. "From the
lowest levels of carbon monoxide, we are
seeing an increase in hospital admissions
with rising pollutant," Morris says. "If
future studies do establish a minimum CO
effect threshold, that may impact EPA air
standards."
The EPA attempts to control CO pol-
lution by regulating motor vehicle emis-
sions. The Clean AirAct of 1990 strength-
ened tests for auto emission standards and
required oxygenated gasolines, with addi-
tives to improve fuel efficiency, for metro-
politan areas with high CO levels.
Morris next plans to study exposure to
another common auto pollutant: fine com-
bustion particles. "It's possible that this
pollutant, along with carbon monoxide,
contributes to the heart failure admissions
we reported," Morris says. "Nowwe've got
to separate the two pollutants and find out
how important each one is."
Barking up the Right Tree?
People may now have one more reason to
save trees: they might someday save your
life. In a recent study at the University of
Illinois at Chicago, a compound called
betulinic acid, derived from the bark of
white birch trees, has been shown to halt
the growth ofmelanoma cancer cells. More
importandy, the compound selectively tar-
gets these cells, providing hope that a
chemotherapeutic drug developed from
betulinic acid will have very few side
effects.
The compoundwas originally extracted
from the bark ofan African tree, Ziziphus
mauritiana lam (Rhamnaceae). It was later
found in the bark of the common white
birch. Unlike extracting taxol, another
chemotherapeutic substance obtained from
tree bark, the process to extract betulinic
acid is relativelysimple, involving a chloro-
form extraction andcrystallization process.
Betulinic acid was shown to be ahighly
effective antitumor agent in a study pub-
lished in the October 1995 issue ofNature
Medicine. The study reported on a success-
ful series of cell culture experiments with
four human melanoma cell lines (derived
from lymph node, lung fluid, liver, and
skin). The growth of the cell cultures was
specifically inhibited using half the maxi-
mal effective doses of 1-5 micrograms per
milliliter. Researchers tested the compound
in immune-suppressed mice that had been
induced to develop human melanomas. In
these experiments, tumor growth was
either inhibited significantly or halted in
the treated group. A drug called DTIC
(dacarbazine), commonly used to treat
human melanoma, was used as one ofthe
positive controls. The betulinic acid-treat-
ed mice showed three times greater tumor
inhibition than the DTIC-treated mice.
"These results are very encouraging,"
says John Pezzuto, director ofthe Program
ofCollaborative Research at the University
of Illinois. "Of the thousands of agents
screened, betulinic acid is one of the best
compounds to come out ofour lab in the
last five years." A potentially beneficial
property of betulinic acid is that it does
not appear to affect other human cancer
cell types, suggesting a unique specificity
for melanoma that may shed light on the
mechanisms of this disease. Current anti-
neoplastic agents such as captothecin,
taxol, and vinblastine are toxic to multiple
cell types, resulting in damage to normal
tissue.
Several pharmaceutical companies have
shown interest in funding the development
ofbetulinic acid. According to Pezzuto, in
vivo tests are continuing and will be fol-
lowed by rigorous toxicity testing. If the
results are positive, an investigative new
drug application may be filed with the
FDA as early as 1996, allowing human
dinical trials to begin.
In addition to treating malignant
melanoma, a disease that strikes 1 in 90
Americans, the compound may someday
be used to prevent and treat other skin
cancers. Skin cancers, with about 800,000
new cases per year, are the most frequent
type of cancer in the United States. The
compound's efficacy will eventually also be
tested against a variety of other tumor
types such as neuroblastoma, a type of
brain tumor. In addition, because of its
emerging excellent safety profile, Pezzuto
envisions betulinic acid's potential useful-
ness in consumer products such as sun-
screens.
According to one expert, it may be too
soon to tell the real potential for this bark
extract. Antonio Buzaid, a melanoma spe-
cialist at the University of Texas MD
Anderson Cancer Center, recently com-
mented in Science News that "in most
cases, such effective drugs don't pan out in
people." This caution is echoed by Don
Morton, medical director and chief of
surgery at the John Wayne Cancer
Institute, who conducts research on
Made in the shade. A substanc'e isolated from
the bark of white birch trees shows promise
for treating melanomas.
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melanoma vaccines. Morton, however,
expresses optimism about the October
study results and describes betulinic acid as
one of the most exciting and unique com-
pounds currently under investigation for
treatment ofmelanoma.
An Environmental Nobel
Twenty years ago, when Mario Molina
described his research to friends, they
would look baffled, perhaps even a little
worried about his state of mind. Then a
postdoctoral fellow at the University of
California, Irvine, Molina would explain
how an invisible gas sprayed out ofaerosol
cans could float up to the stratosphere,
about 8-12 miles above the earth's surface,
and create havoc with the ozone, which
protects living things on earth from short-
er-wave length ultraviolet radiation. "Only
a few people were aware ofthe ozone prob-
lem in those days, because it was such a
specialized topic," says Molina, now a pro-
fessor of environmental science at the
Massachusetts Institute of Technology.
"But a decade later, when the public had a
better understanding of what humans can
do to the planet, I became amazed at how
many people were knowledgeable about
the depletion ofthe ozone layer."
In 1995, Molina shared the Nobel
Prize in Chemistry with colleagues F.
Sherwood Rowland, professor ofchemistry
at the University ofCalifornia, Irvine, and
Paul Crutzen of Max-Planck Institute for
Chemistry, in Mainz, Germany, for their
work in atmospheric chemistry, especially
on the formation and destruction ofozone.
The researchers have made crucial discov-
eries showing how chemical emissions
from air conditioners, aerosol cans, and fire
extinguishers can dramatically increase the
destructive processes ofthe sensitive ozone
layer, our planet's "Achilles heel," said the
Royal Swedish Academy in its award cita-
tion on October 11. As ozone is depleted,
more of the sun's dangerous ultraviolet
rays can reach the earth causing additional
skin cancers, cataracts, and damage to the
immune system, but also harming ecosys-
tems. By sounding the alarm about ozone
damage, the researchers "have contributed
to our salvation from a global environmen-
tal problem that could have catastrophic
consequences," the academy said.
In 1970, Paul Crutzen was the first sci-
entist to identify one of the important
processes that create a natural balance in
stratospheric ozone. Crutzen discovered that
when nitrous oxide, which is produced by
soil bacteria, floats up to the stratosphere,
the chemical demolishes ozone molecules.
Crutzen's research led directly to discoveries
on the relationship between ozone destruc-
tion and freon compounds manufactured
with chlorofluorcarbons (CFCs), says Jack
Calvert, atmospheric scientist at the
National Center for Atmospheric Research
in Boulder, Colorado. "When nitrous
oxides get to the stratosphere, they start a
chemical chain reaction that destroys
ozone, in the same way that freon does,"
Calvert says.
In fact, small amounts ofother natural
compounds, hydrogen and chlorine, also
migrate from the earth's surface and break
down ozone molecules in the stratosphere.
But until industrial chemicals changed the
atmosphere's chemical mix, this destruc-
tion was generally balanced by natural pro-
duction of ozone. That is, the sun's rays
would split oxygen molecules and start a
rapid chemical reaction, leading to the for-
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mation ofozone molecules. So the amount
of ozone would increase or decrease by
small degrees, depending on chemical
influences from volcanic eruptions and sea-
sonal changes, and on variations in the
sun's intensity.
Crutzen was also among the first scien-
tists to suspect that human-made chemi-
cals could deplete ozone. In the early
1970s, Crutzen and Harold S. Johnston, a
chemistry professor at the University of
California, Berkeley, theorized that a new
kind of commercial airplane called the
supersonic transport (SST), which flew
into the stratosphere and spewed nitrogen
oxides from its exhaust, could accelerate
natural destruction ofozone.
Meanwhile, by 1973, Rowland and
Molina theorized that CFCs could migrate
into the upper atmosphere and damage
ozone. The researchers calculated that
because CFCs are so stable and durable in
the surface atmosphere, the chemicals can
live for 50-100 years, but when they reach
the stratosphere, they are disintegrated by
shorter-wave ultraviolet radiation. As each
chlorine molecule breaks down, it can
destroy many ozone molecules, possibly
depleting ozone, on a global average, by
7-13% over 100 years if CFC production
continued at its rate of growth (at that
time), Molina and Rowland theorized.
With further research, though, the sci-
entists learned that ozone would be deplet-
ed in more complex ways. "Later, we real-
ized that there would be large depletions of
ozone at different latitudes, and more
severe depletions at high latitudes," says
Molina.
In 1975, researchers from the National
Center for Atmospheric Research and the
National Oceanic and Atmospheric
Administration separately reported that
instruments on balloons had detected
abundant CFC-1 1 in the stratosphere.
This was the first time that measurements
had been made ofany manufactured chlo-
rine compounds in the upper atmosphere.
The next year, a special National Academy
of Sciences panel calculated that stratos-
pheric ozone could be depleted by 7% over
the long-term due to CFCs, within the
range first estimated by Rowland and
Molina. In presentations at scientific meet-
ings, press conferences, and legislative
hearings, Rowland and Molina began rec-
ommending a complete ban on the release
ofCFCs to the atmosphere.
By 1979, the United States and other
nations had banned the sale ofaerosol cans
that contained CFCs, but companies con-
tinued to produce CFCs for other uses.
Moreover, there was no urgency by the
international community to ban CFCs
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